I agree that this site is using cookies. You can find further informations here.
X
Nagy, Rebecca
355  results:
Search for persons X
?
1

NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab..:

Jacobs, Samuel A. ; Wang, Ying ; Abraham, Jame...
Breast Cancer Research.  26 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Correction: NSABP FB-10: a phase Ib/II trial evaluating ado..:

Jacobs, Samuel A. ; Wang, Ying ; Abraham, Jame...
Breast Cancer Research.  26 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Determinants of Survival with Combined HER2 and PD-1 Blocka..:

Maron, Steven B. ; Chatila, Walid ; Walch, Henry...
Clinical Cancer Research.  29 (2023)  18 - p. 3633-3640 , 2023
Link: https://doi.org/10.1158/..
 
?
4

Building Your Career as a Crime Analyst:

, In: The Crime Analyst's Companion,
Nagy, Rebecca - p. 73-79 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Serial ctDNA analysis predicts clinical progression in pati..:

Shohdy, Kyrillus S. ; Villamar, Dario M. ; Cao, Yen...
British Journal of Cancer.  126 (2022)  3 - p. 430-439 , 2022
Link: https://doi.org/10.1038/..
 
?
6

Up-front cell-free DNA next generation sequencing improves ..:

Cui, Wanyuan ; Milner-Watts, Charlotte ; O'Sullivan, Hazel...
European Journal of Cancer.  171 (2022)  - p. 44-54 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Detection of tier 1 variants with circulating tumour (ct) D..:

Milner-Watts, Charlotte ; Lyons, Hannah ; Cui, Wanyuan...
Lung Cancer.  156 (2021)  - p. S28 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Molecular Landscape of BRAF-Mutant NSCLC Reveals an Associa..:

Negrao, Marcelo V. ; Raymond, Victoria M. ; Lanman, Richard B....
Journal of Thoracic Oncology.  15 (2020)  10 - p. 1611-1623 , 2020
Link: https://doi.org/10.1016/..
 
?
9

First-line pembrolizumab and trastuzumab in HER2-positive o..:

Janjigian, Yelena Y ; Maron, Steven B ; Chatila, Walid K...
The Lancet Oncology.  21 (2020)  6 - p. 821-831 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Circulating Tumor DNA Alterations in Advanced Urothelial Ca..:

Grivas, Petros ; Lalani, Aly-Khan A. ; Pond, Gregory R....
European Urology Oncology.  3 (2020)  5 - p. 695-699 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Blood-based next-generation sequencing analysis of neuroend..:

Zakka, Katerina ; Nagy, Rebecca ; Drusbosky, Leylah...
Oncotarget.  11 (2020)  19 - p. 1749-1757 , 2020
Link: https://doi.org/10.18632..
 
?
12

Aberrant FGFR signaling mediates resistance to CDK4/6 inhib..:

Formisano, Luigi ; Lu, Yao ; Servetto, Alberto...
Nature Communications.  10 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
13

BRAF Mutations Classes I, II, and III in NSCLC Patients Inc..:

Bracht, Jillian Wilhelmina Paulina ; Karachaliou, Niki ; Bivona, Trever...
Cancers.  11 (2019)  9 - p. 1381 , 2019
Link: https://doi.org/10.3390/..
 
?
14

Comprehensive Analysis of AR Alterations in Circulating Tum..:

Ledet, Elisa M. ; Lilly, Michael B. ; Sonpavde, Guru...
The Oncologist.  25 (2019)  4 - p. 327-333 , 2019
Link: https://doi.org/10.1634/..
 
?
15

Identification of osimertinib-resistant EGFR L792 mutations..:

Fairclough, Stephen R. ; Kiedrowski, Lesli A. ; Lin, Jessica J....
Experimental Hematology & Oncology.  8 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
1-15